These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 6538653

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Phase II study of aziridinylbenzoquinone (AZQ) in patients with central nervous system malignancies: a Southwest Oncology Group Study.
    Taylor SA, McCracken JD, Eyre HJ, O'Bryan RM, Neilan BA.
    J Neurooncol; 1985; 3(2):131-5. PubMed ID: 2993536
    [Abstract] [Full Text] [Related]

  • 6. Preliminary communication--treatment of primary brain tumors recurrent after irradiation with aziridinylbenzoquinone (AZQ;NSC-182986).
    Eagan RT, Dinapoli RP, Hermann RC, Groover RV, Layton DD.
    Am J Clin Oncol; 1983 Oct; 6(5):577-8. PubMed ID: 6613923
    [Abstract] [Full Text] [Related]

  • 7. Phase II study of aziridinylbenzoquinone (AZQ: NSC-182986) in the treatment of malignant gliomas recurrent after radiation. Preliminary report.
    Decker DA, Al Sarraf M, Kresge C, Austin D, Wilner HI.
    J Neurooncol; 1985 Oct; 3(1):19-21. PubMed ID: 2987424
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. A phase II study of diaziquone in children with recurrent or progressive primary brain tumors: a report from the Childrens Cancer Study Group.
    Ettinger LJ, Ru N, Krailo M, Ruccione KS, Krivit W, Hammond GD.
    J Neurooncol; 1990 Aug; 9(1):69-76. PubMed ID: 2213117
    [Abstract] [Full Text] [Related]

  • 16. A phase II study of diaziquone in childhood leukemia: a report from the Children's Cancer Study Group.
    Ettinger LJ, Krailo M, Ruccione KS, Krivit W, Hammond GD.
    Am J Pediatr Hematol Oncol; 1988 Aug; 10(1):18-22. PubMed ID: 3189713
    [Abstract] [Full Text] [Related]

  • 17. Randomized comparison of diaziquone and carmustine in the treatment of adults with anaplastic glioma.
    Schold SC, Herndon JE, Burger PC, Halperin EC, Vick NA, Cairncross JG, Macdonald DR, Dropcho EJ, Morawetz R, Bigner DD.
    J Clin Oncol; 1993 Jan; 11(1):77-83. PubMed ID: 8418246
    [Abstract] [Full Text] [Related]

  • 18. Response rate and toxicity with aziridinylbenzoquinone in patients with recurrent gliomas. A progress report.
    Tapazoglou E, Kish J, Ensley J, Al-Sarraf M.
    Am J Clin Oncol; 1988 Aug; 11(4):474-8. PubMed ID: 3407628
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Phase II evaluation of diaziquone (CI-904, AZQ) in the treatment of human malignant glioma.
    Maral J, Poisson M, Pertuiset BF, Mashaly P, Weil M, Jacquillat C, Grillo-Lopez AJ.
    J Neurooncol; 1985 Aug; 3(3):245-9. PubMed ID: 4056853
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.